Efficacy of the Unified Protocol for transdiagnostic treatment of comorbid psychopathology accompanying emotional disorders compared to treatments targeting single disorders

Stephanie Jarvi Steele, Todd J Farchione, Clair Cassiello-Robbins, Amantia Ametaj, Sophia Sbi, Shannon Sauer-Zavala, David H Barlow, Stephanie Jarvi Steele, Todd J Farchione, Clair Cassiello-Robbins, Amantia Ametaj, Sophia Sbi, Shannon Sauer-Zavala, David H Barlow

Abstract

Objective: This study aimed to examine whether the Unified Protocol (UP), a transdiagnostic cognitive-behavioral therapy for emotional disorders (i.e., anxiety, mood, and related disorders), is efficacious in the treatment of co-occurring emotional disorders compared to established single disorder protocols (SDPs) that target specific disorders (e.g., panic disorder).

Method: Participants included 179 adults seeking outpatient psychotherapy. Participant age ranged from 18 to 66 years, with an average of 30.66 years (SD = 10.77). The sample was 55% female and mostly Caucasian (83%). Diagnostic assessments were completed with the Anxiety Disorder Interview Schedule (ADIS), and disorder-specific, clinician-rated measures for the comorbid diagnoses of interest.

Results: In both treatment conditions, participants' mean number of diagnoses dropped significantly from baseline to posttreatment, and baseline to 12-month follow-up. Additionally, large effects were observed for changes in comorbid generalized anxiety (ESSG: UP = -1.72; SDP = -1.98), social anxiety (ESSG: UP = -1.33, -0.86; SDP = -1.60, -1.54), and depression (ESSG: UP = -0.83; SDP = -0.84). Significant differences were not observed in between-group comparisons.

Conclusions: Results suggest that both the UP and SDPs are efficacious in reducing symptoms of comorbid emotional disorders. The clinical, practical, and cost-effective advantages of transdiagnostic CBT are discussed.

Keywords: Cognitive-behavioral therapy; Comorbidity; Emotional disorders; Transdiagnostic treatment; Unified protocol.

Conflict of interest statement

Conflict of Interest

Please note the following financial disclosures/conflicts of interest: Dr. Barlow reported receiving royalties from Oxford University Press (which includes royalties for the treatment manuals included in this study), Guilford Publications Inc., Cengage Learning, and Pearson Publishing; receiving grants from the National Institute of Mental Health, the National Institute of Alcohol and Alcohol Abuse, and Colciencias (Government of Columbia Initiative for Science, Technology, and Health Innovation); serving as a consultant for and receiving honoraria from the Agency for Healthcare Research and Quality, the Foundation for Informed Medical Decision Making, the Department of Defense, the Renfrew Center, the Chinese University of Hong Kong, Universidad Catolica de Santa Maria (Arequipa, Peru), New Zealand Psychological Association, Hebrew University of Jerusalem, Mayo Clinic, and various American universities.

Drs. Farchione and Sauer-Zavala reported receiving royalties from Oxford University Press (for one of the treatment manuals included in this study). No other disclosures were reported.

Copyright © 2018 Elsevier Ltd. All rights reserved.

Figures

Figure 1.
Figure 1.
Recruitment Flow Diagram

Source: PubMed

3
Tilaa